img

Global Acute Intermittent Porphyria Drugs Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Acute Intermittent Porphyria Drugs Market Research Report 2024

Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias.
According to Mr Accuracy reports new survey, global Acute Intermittent Porphyria Drugs market is projected to reach US$ 56 million in 2029, increasing from US$ 49 million in 2022, with the CAGR of 1.8% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Acute Intermittent Porphyria Drugs market research.
Panhematin (hemin) is a medication used to treat acute porphyria, a rare genetic disorder that affects heme production. Its effectiveness in managing acute porphyria attacks and reducing symptoms has driven market growth. The rarity of the condition and limited treatment options contribute to its niche status. However, challenges include the need for careful monitoring and potential side effects. The market competition is relatively small, as Panhematin remains a specialized therapy.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Acute Intermittent Porphyria Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Recordati Rare Diseases
Segment by Type
350mg
313mg

Segment by Application


Hospital
Pharmacy

Consumption by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Acute Intermittent Porphyria Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Acute Intermittent Porphyria Drugs Market Overview
1.1 Product Overview and Scope of Acute Intermittent Porphyria Drugs
1.2 Acute Intermittent Porphyria Drugs Segment by Type
1.2.1 Global Acute Intermittent Porphyria Drugs Market Value Comparison by Type (2024-2034)
1.2.2 350mg
1.2.3 313mg
1.3 Acute Intermittent Porphyria Drugs Segment by Application
1.3.1 Global Acute Intermittent Porphyria Drugs Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Acute Intermittent Porphyria Drugs Market Size Estimates and Forecasts
1.4.1 Global Acute Intermittent Porphyria Drugs Revenue 2018-2029
1.4.2 Global Acute Intermittent Porphyria Drugs Sales 2018-2029
1.4.3 Global Acute Intermittent Porphyria Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Acute Intermittent Porphyria Drugs Market Competition by Manufacturers
2.1 Global Acute Intermittent Porphyria Drugs Sales Market Share by Manufacturers (2018-2024)
2.2 Global Acute Intermittent Porphyria Drugs Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Acute Intermittent Porphyria Drugs Average Price by Manufacturers (2018-2024)
2.4 Global Acute Intermittent Porphyria Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Acute Intermittent Porphyria Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Acute Intermittent Porphyria Drugs, Product Type & Application
2.7 Acute Intermittent Porphyria Drugs Market Competitive Situation and Trends
2.7.1 Acute Intermittent Porphyria Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Acute Intermittent Porphyria Drugs Players Market Share by Revenue
2.7.3 Global Acute Intermittent Porphyria Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Acute Intermittent Porphyria Drugs Retrospective Market Scenario by Region
3.1 Global Acute Intermittent Porphyria Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Acute Intermittent Porphyria Drugs Global Acute Intermittent Porphyria Drugs Sales by Region: 2018-2029
3.2.1 Global Acute Intermittent Porphyria Drugs Sales by Region: 2018-2024
3.2.2 Global Acute Intermittent Porphyria Drugs Sales by Region: 2024-2029
3.3 Global Acute Intermittent Porphyria Drugs Global Acute Intermittent Porphyria Drugs Revenue by Region: 2018-2029
3.3.1 Global Acute Intermittent Porphyria Drugs Revenue by Region: 2018-2024
3.3.2 Global Acute Intermittent Porphyria Drugs Revenue by Region: 2024-2029
3.4 North America Acute Intermittent Porphyria Drugs Market Facts & Figures by Country
3.4.1 North America Acute Intermittent Porphyria Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Acute Intermittent Porphyria Drugs Sales by Country (2018-2029)
3.4.3 North America Acute Intermittent Porphyria Drugs Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Acute Intermittent Porphyria Drugs Market Facts & Figures by Country
3.5.1 Europe Acute Intermittent Porphyria Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Acute Intermittent Porphyria Drugs Sales by Country (2018-2029)
3.5.3 Europe Acute Intermittent Porphyria Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Acute Intermittent Porphyria Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Acute Intermittent Porphyria Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Acute Intermittent Porphyria Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Acute Intermittent Porphyria Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Acute Intermittent Porphyria Drugs Market Facts & Figures by Country
3.7.1 Latin America Acute Intermittent Porphyria Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Acute Intermittent Porphyria Drugs Sales by Country (2018-2029)
3.7.3 Latin America Acute Intermittent Porphyria Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Acute Intermittent Porphyria Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Acute Intermittent Porphyria Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Acute Intermittent Porphyria Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Acute Intermittent Porphyria Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Acute Intermittent Porphyria Drugs Sales by Type (2018-2029)
4.1.1 Global Acute Intermittent Porphyria Drugs Sales by Type (2018-2024)
4.1.2 Global Acute Intermittent Porphyria Drugs Sales by Type (2024-2029)
4.1.3 Global Acute Intermittent Porphyria Drugs Sales Market Share by Type (2018-2029)
4.2 Global Acute Intermittent Porphyria Drugs Revenue by Type (2018-2029)
4.2.1 Global Acute Intermittent Porphyria Drugs Revenue by Type (2018-2024)
4.2.2 Global Acute Intermittent Porphyria Drugs Revenue by Type (2024-2029)
4.2.3 Global Acute Intermittent Porphyria Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Acute Intermittent Porphyria Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Acute Intermittent Porphyria Drugs Sales by Application (2018-2029)
5.1.1 Global Acute Intermittent Porphyria Drugs Sales by Application (2018-2024)
5.1.2 Global Acute Intermittent Porphyria Drugs Sales by Application (2024-2029)
5.1.3 Global Acute Intermittent Porphyria Drugs Sales Market Share by Application (2018-2029)
5.2 Global Acute Intermittent Porphyria Drugs Revenue by Application (2018-2029)
5.2.1 Global Acute Intermittent Porphyria Drugs Revenue by Application (2018-2024)
5.2.2 Global Acute Intermittent Porphyria Drugs Revenue by Application (2024-2029)
5.2.3 Global Acute Intermittent Porphyria Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Acute Intermittent Porphyria Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Recordati Rare Diseases
6.1.1 Recordati Rare Diseases Corporation Information
6.1.2 Recordati Rare Diseases Description and Business Overview
6.1.3 Recordati Rare Diseases Acute Intermittent Porphyria Drugs Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Recordati Rare Diseases Acute Intermittent Porphyria Drugs Product Portfolio
6.1.5 Recordati Rare Diseases Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Acute Intermittent Porphyria Drugs Industry Chain Analysis
7.2 Acute Intermittent Porphyria Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Acute Intermittent Porphyria Drugs Production Mode & Process
7.4 Acute Intermittent Porphyria Drugs Sales and Marketing
7.4.1 Acute Intermittent Porphyria Drugs Sales Channels
7.4.2 Acute Intermittent Porphyria Drugs Distributors
7.5 Acute Intermittent Porphyria Drugs Customers
8 Acute Intermittent Porphyria Drugs Market Dynamics
8.1 Acute Intermittent Porphyria Drugs Industry Trends
8.2 Acute Intermittent Porphyria Drugs Market Drivers
8.3 Acute Intermittent Porphyria Drugs Market Challenges
8.4 Acute Intermittent Porphyria Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Acute Intermittent Porphyria Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Acute Intermittent Porphyria Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Acute Intermittent Porphyria Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Acute Intermittent Porphyria Drugs Sales (Units) of Key Manufacturers (2018-2024)
Table 5. Global Acute Intermittent Porphyria Drugs Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Acute Intermittent Porphyria Drugs Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Acute Intermittent Porphyria Drugs Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Acute Intermittent Porphyria Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Acute Intermittent Porphyria Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Acute Intermittent Porphyria Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Acute Intermittent Porphyria Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Acute Intermittent Porphyria Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Acute Intermittent Porphyria Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Intermittent Porphyria Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Acute Intermittent Porphyria Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Acute Intermittent Porphyria Drugs Sales by Region (2018-2024) & (Units)
Table 18. Global Acute Intermittent Porphyria Drugs Sales Market Share by Region (2018-2024)
Table 19. Global Acute Intermittent Porphyria Drugs Sales by Region (2024-2029) & (Units)
Table 20. Global Acute Intermittent Porphyria Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Acute Intermittent Porphyria Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Acute Intermittent Porphyria Drugs Revenue Market Share by Region (2018-2024)
Table 23. Global Acute Intermittent Porphyria Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Acute Intermittent Porphyria Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Acute Intermittent Porphyria Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Acute Intermittent Porphyria Drugs Sales by Country (2018-2024) & (Units)
Table 27. North America Acute Intermittent Porphyria Drugs Sales by Country (2024-2029) & (Units)
Table 28. North America Acute Intermittent Porphyria Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Acute Intermittent Porphyria Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Acute Intermittent Porphyria Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Acute Intermittent Porphyria Drugs Sales by Country (2018-2024) & (Units)
Table 32. Europe Acute Intermittent Porphyria Drugs Sales by Country (2024-2029) & (Units)
Table 33. Europe Acute Intermittent Porphyria Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Acute Intermittent Porphyria Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Acute Intermittent Porphyria Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Acute Intermittent Porphyria Drugs Sales by Region (2018-2024) & (Units)
Table 37. Asia Pacific Acute Intermittent Porphyria Drugs Sales by Region (2024-2029) & (Units)
Table 38. Asia Pacific Acute Intermittent Porphyria Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Acute Intermittent Porphyria Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Acute Intermittent Porphyria Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Acute Intermittent Porphyria Drugs Sales by Country (2018-2024) & (Units)
Table 42. Latin America Acute Intermittent Porphyria Drugs Sales by Country (2024-2029) & (Units)
Table 43. Latin America Acute Intermittent Porphyria Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Acute Intermittent Porphyria Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Acute Intermittent Porphyria Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Acute Intermittent Porphyria Drugs Sales by Country (2018-2024) & (Units)
Table 47. Middle East & Africa Acute Intermittent Porphyria Drugs Sales by Country (2024-2029) & (Units)
Table 48. Middle East & Africa Acute Intermittent Porphyria Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Acute Intermittent Porphyria Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Acute Intermittent Porphyria Drugs Sales (Units) by Type (2018-2024)
Table 51. Global Acute Intermittent Porphyria Drugs Sales (Units) by Type (2024-2029)
Table 52. Global Acute Intermittent Porphyria Drugs Sales Market Share by Type (2018-2024)
Table 53. Global Acute Intermittent Porphyria Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Acute Intermittent Porphyria Drugs Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Acute Intermittent Porphyria Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Acute Intermittent Porphyria Drugs Revenue Market Share by Type (2018-2024)
Table 57. Global Acute Intermittent Porphyria Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Acute Intermittent Porphyria Drugs Price (USD/Unit) by Type (2018-2024)
Table 59. Global Acute Intermittent Porphyria Drugs Price (USD/Unit) by Type (2024-2029)
Table 60. Global Acute Intermittent Porphyria Drugs Sales (Units) by Application (2018-2024)
Table 61. Global Acute Intermittent Porphyria Drugs Sales (Units) by Application (2024-2029)
Table 62. Global Acute Intermittent Porphyria Drugs Sales Market Share by Application (2018-2024)
Table 63. Global Acute Intermittent Porphyria Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Acute Intermittent Porphyria Drugs Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Acute Intermittent Porphyria Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Acute Intermittent Porphyria Drugs Revenue Market Share by Application (2018-2024)
Table 67. Global Acute Intermittent Porphyria Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Acute Intermittent Porphyria Drugs Price (USD/Unit) by Application (2018-2024)
Table 69. Global Acute Intermittent Porphyria Drugs Price (USD/Unit) by Application (2024-2029)
Table 70. Recordati Rare Diseases Corporation Information
Table 71. Recordati Rare Diseases Description and Business Overview
Table 72. Recordati Rare Diseases Acute Intermittent Porphyria Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Recordati Rare Diseases Acute Intermittent Porphyria Drugs Product
Table 74. Recordati Rare Diseases Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Acute Intermittent Porphyria Drugs Distributors List
Table 78. Acute Intermittent Porphyria Drugs Customers List
Table 79. Acute Intermittent Porphyria Drugs Market Trends
Table 80. Acute Intermittent Porphyria Drugs Market Drivers
Table 81. Acute Intermittent Porphyria Drugs Market Challenges
Table 82. Acute Intermittent Porphyria Drugs Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Acute Intermittent Porphyria Drugs
Figure 2. Global Acute Intermittent Porphyria Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Acute Intermittent Porphyria Drugs Market Share by Type in 2022 & 2029
Figure 4. 350mg Product Picture
Figure 5. 313mg Product Picture
Figure 6. Global Acute Intermittent Porphyria Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Acute Intermittent Porphyria Drugs Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Global Acute Intermittent Porphyria Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Acute Intermittent Porphyria Drugs Market Size (2018-2029) & (US$ Million)
Figure 12. Global Acute Intermittent Porphyria Drugs Sales (2018-2029) & (Units)
Figure 13. Global Acute Intermittent Porphyria Drugs Average Price (USD/Unit) & (2018-2029)
Figure 14. Acute Intermittent Porphyria Drugs Report Years Considered
Figure 15. Acute Intermittent Porphyria Drugs Sales Share by Manufacturers in 2022
Figure 16. Global Acute Intermittent Porphyria Drugs Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Acute Intermittent Porphyria Drugs Players: Market Share by Revenue in 2022
Figure 18. Acute Intermittent Porphyria Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Acute Intermittent Porphyria Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Acute Intermittent Porphyria Drugs Sales Market Share by Country (2018-2029)
Figure 21. North America Acute Intermittent Porphyria Drugs Revenue Market Share by Country (2018-2029)
Figure 22. the United States Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Acute Intermittent Porphyria Drugs Sales Market Share by Country (2018-2029)
Figure 25. Europe Acute Intermittent Porphyria Drugs Revenue Market Share by Country (2018-2029)
Figure 26. Germany Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. UK Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Acute Intermittent Porphyria Drugs Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Acute Intermittent Porphyria Drugs Revenue Market Share by Region (2018-2029)
Figure 33. China Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Acute Intermittent Porphyria Drugs Sales Market Share by Country (2018-2029)
Figure 43. Latin America Acute Intermittent Porphyria Drugs Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Acute Intermittent Porphyria Drugs Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Acute Intermittent Porphyria Drugs Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Acute Intermittent Porphyria Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Acute Intermittent Porphyria Drugs by Type (2018-2029)
Figure 53. Global Revenue Market Share of Acute Intermittent Porphyria Drugs by Type (2018-2029)
Figure 54. Global Acute Intermittent Porphyria Drugs Price (USD/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Acute Intermittent Porphyria Drugs by Application (2018-2029)
Figure 56. Global Revenue Market Share of Acute Intermittent Porphyria Drugs by Application (2018-2029)
Figure 57. Global Acute Intermittent Porphyria Drugs Price (USD/Unit) by Application (2018-2029)
Figure 58. Acute Intermittent Porphyria Drugs Value Chain
Figure 59. Acute Intermittent Porphyria Drugs Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed